Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lalloo

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
The British Journal of Surgery|April 6, 2007
Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutationsD Speake, D G Evans, F Lalloo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 18, 2000
A protocol for preventative mastectomy in women with an increased lifetime risk of breast cancerF Lalloo, A Baildam, A Brain, et al.
Clinical Genetics|February 6, 2015
Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care surveyP Barrow, K Green, T Clancy, et al.
Clinical Genetics|March 4, 2008
Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer familiesD G R Evans, K Young, M Bulman, et al.
Breast Cancer Research and Treatment|February 19, 2016
Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screensD G Evans, F Lalloo, S Howell, et al.
Journal of Medical Genetics|July 1, 2010
Risk of breast cancer in male BRCA2 carriersD G R Evans, I Susnerwala, J Dawson, et al.
Journal of Medical Genetics|February 25, 1998
An evaluation of common breast cancer gene mutations in a population of Ashkenazi JewsF Lalloo, S Cochrane, B Bulman, et al.
Breast Cancer Research and Treatment|November 9, 2017
Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriersD G Evans, E F Harkness, S Howel, et al.
Familial Cancer|November 1, 2016
Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scoresD G Evans, E R Woodward, S J Howell, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 1998
Screening by mammography, women with a family history of breast cancerF Lalloo, C R Boggis, D G Evans, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
The British Journal of Surgery|April 6, 2007
Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutationsD Speake, D G Evans, F Lalloo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 18, 2000
A protocol for preventative mastectomy in women with an increased lifetime risk of breast cancerF Lalloo, A Baildam, A Brain, et al.
Clinical Genetics|February 6, 2015
Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care surveyP Barrow, K Green, T Clancy, et al.
Clinical Genetics|March 4, 2008
Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer familiesD G R Evans, K Young, M Bulman, et al.
Breast Cancer Research and Treatment|February 19, 2016
Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screensD G Evans, F Lalloo, S Howell, et al.
Journal of Medical Genetics|July 1, 2010
Risk of breast cancer in male BRCA2 carriersD G R Evans, I Susnerwala, J Dawson, et al.
Journal of Medical Genetics|February 25, 1998
An evaluation of common breast cancer gene mutations in a population of Ashkenazi JewsF Lalloo, S Cochrane, B Bulman, et al.
Breast Cancer Research and Treatment|November 9, 2017
Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriersD G Evans, E F Harkness, S Howel, et al.
Familial Cancer|November 1, 2016
Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scoresD G Evans, E R Woodward, S J Howell, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 1998
Screening by mammography, women with a family history of breast cancerF Lalloo, C R Boggis, D G Evans, et al.
Pageof 7